← back to search
Bimal Malhotra
Pfizer (United States) · US
Area of research
Urology · Pharmacology
Research interest
Research interests include Urinary Bladder and Prostate Research, Pharmacogenetics and Drug Metabolism, Pain Management and Opioid Use, and Opioid Use Disorder Treatment.
h-index
23
citations
2,056
works
86
NIH funding
—
primary concept
Medicine
email
bimal.k.malhotra@pfizer.com
Recent publications
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
New England Journal of Medicine
2021
cited by
443
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Ricardo Rojo
· Pfizer (United States)
1
papers (2021–2021)
Jonathan I. Silverberg
· Maimonides Medical Center
1
papers (2021–2021)
Ileana A. Ionita
· Pfizer (United Kingdom)
1
papers (2021–2021)
Eric L. Simpson
· Eli Lilly (United States)
1
papers (2021–2021)
Andrew Pink
· King's College London
1
papers (2021–2021)
Thomas Bieber
· CK-CARE
1
papers (2021–2021)
Jacek Zdybski
· Akademii Nauk Stosowanych im. Józefa Gołuchowskiego
1
papers (2021–2021)
Pinaki Biswas
· Pfizer (United States)
1
papers (2021–2021)
Rodney Sinclair
· Melbourne Health
1
papers (2021–2021)
Marco DiBonaventura
· Pfizer (United States)
1
papers (2021–2021)
Chia‐Yu Chu
· National Taiwan Normal University
1
papers (2021–2021)
Yoko Kataoka
· Osaka Prefectural Medical Center
1
papers (2021–2021)
Seth Forman
· Skin Cancer Foundation
1
papers (2021–2021)
C. Paul
· Centre National de la Recherche Scientifique
1
papers (2021–2021)
Jeremias Antinew
· Pfizer (United States)
1
papers (2021–2021)
Diamant Thaçi
· Boehringer Ingelheim (Germany)
1
papers (2021–2021)
Hernán Valdez
· Pfizer (United States)
1
papers (2021–2021)
Fan Zhang
· Stanford University
1
papers (2021–2021)